OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyper‐inflammation and complement in COVID‐19
Bruno Garcia Pires, Rodrigo T. Calado
American Journal of Hematology (2023) Vol. 98, Iss. S4
Open Access | Times Cited: 17

Showing 17 citing articles:

SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14

Endotheliopathy in Acute COVID-19 and Long COVID
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8237-8237
Open Access | Times Cited: 30

mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions
Tamás Bakos, Tamás Mészáros, Gergely Tibor Kozma, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3595-3595
Open Access | Times Cited: 10

Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective
Didar Murad, Rehan Zafar Paracha, Maryum Nisar
Frontiers in Immunology (2025) Vol. 15
Open Access

sMR and PTX3 levels associate with COVID-19 outcome and survival but not with Long COVID
Lisa Hurler, Federica Mescia, Laura Bergamaschi, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110162-110162
Open Access | Times Cited: 2

Predictors of COVID-19 Severity in Elderly Patients Infected by Omicron in China, 18 December 2022–5 February 2023
Y. Xing, Yupeng Li, Liting Feng, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 4505-4518
Open Access | Times Cited: 5

Optimizing the use of vilobelimab for the treatment of COVID-19
Matthew W. McCarthy
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 9, pp. 877-881
Closed Access | Times Cited: 4

A novel monospecific tetravalent IgG1-(scFv)2 version shown enhanced neutralizing and Fc-mediated effector functions against SARS-CoV-2
Zhangzhao Gao, Jingyu Jiao, Yaqiong Zhou, et al.
3 Biotech (2023) Vol. 13, Iss. 8
Closed Access | Times Cited: 2

Fish decay-accelerating factor (DAF) regulates intestinal complement pathway and immune response to bacterial challenge
Xia Zhang, Yuhan Zhang, Ting Wu, et al.
Fish & Shellfish Immunology (2024) Vol. 151, pp. 109741-109741
Closed Access

SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway
Andrea Kocsis, Dalma Bartus, Edit Hirsch, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7343-7343
Open Access

SARS-CoV-2 protein deposition enhances renal complement activation and aggravates kidney injury in MN after COVID-19
Guoqin Wang, Lei Yang, Xiaoyi Xu, et al.
Kidney International Reports (2024) Vol. 9, Iss. 11, pp. 3145-3155
Open Access

Post-COVID Syndrome in Children: One-Time Survey Study of Parents’ Opinion
D. R. Shagieva, М А Кутлубаев, А Р Рахматуллин
Вопросы современной педиатрии (2023) Vol. 22, Iss. 3, pp. 254-262
Open Access

Severe COVID-19 outcomes and hematological cancers: the clot thickens—are platelets the culprit?
Lenard M. Lichtenberger, K. Vinod Vijayan
Translational Cancer Research (2023) Vol. 12, Iss. 9, pp. 2425-2428
Open Access

Page 1

Scroll to top